Together, our findings highlight that the HSP60-ClpP–mediated UPRmt facilitates PCa growth and progression, and identify the HSP60-ClpP interaction as a therapeutic vulnerability in PCa. The gene discussed is HSPD1; the disease is posterior cortical atrophy.